Literature DB >> 15167644

Magnetic resonance image-reversible findings in a patient with general paresis.

Angel Berbel-Garcia1, Jesus Porta-Etessam, Antonio Martinez-Salio, Jose Maria Millan-Juncos, David A Perez-Martinez, Rosana A Saiz-Diaz, Maria Toledo-Heras.   

Abstract

MATERIAL AND METHODS: We describe clinical, cerebrospinal fluid (CSF), and magnetic resonance imaging (MRI) findings in a patient with general paresis. MRI demonstrated cortical-subcortical atrophy and broad-coalescent high-intensity T2 lesions in right frontotemporal lobes.
RESULTS: After intravenous penicillin therapy, the size of these lesions diminished dramatically. That regression correlated with improvement in neuropsychologic test and CSF analysis.
CONCLUSION: To our knowledge, this is the first case reported in the literature of MRI-reversible lesions in a patient with general paresis. We suggest that MRI is of prognostic value in patients with general paresis. Severe atrophy, especially in the temporal lobe, could be a marker of bad clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15167644     DOI: 10.1097/00007435-200406000-00006

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  4 in total

1.  Neurosyphilis and paraneoplastic limbic encephalitis: important differential diagnoses.

Authors:  R Scheid; R Voltz; T Vetter; O Sabri; D Y von Cramon
Journal:  J Neurol       Date:  2005-04-01       Impact factor: 4.849

2.  Neurosyphilis: a series of 178 cases at the 3rd-level hospital of Marrakesh (Morocco).

Authors:  Najib Kissani; Sanaa Nafia; Safaa Zahlane; Nisserine Louhab
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-05-03       Impact factor: 3.267

Review 3.  Neurosyphilis.

Authors:  Christina M Marra
Journal:  Curr Neurol Neurosci Rep       Date:  2004-11       Impact factor: 6.030

Review 4.  Neurosyphilis presenting as autoimmune limbic encephalitis: A case report and literature review.

Authors:  Tomotaka Mizoguchi; Makoto Hara; Hideto Nakajima
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.